Status:
RECRUITING
Evolution of Balance and Vestibular Function in Patients Treated With Gammaknife Radiosurgery for Vestibular Schwannoma
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Vestibular Schwannoma
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Vestibular schwannomas are benign lesions of the ponto-cerebellar angle that are potentially dangerous because of their growth in a cramped space and the compressive phenomena they can cause. Stereota...
Detailed Description
Vestibular schwannomas are benign lesions of the ponto-cerebellar angle that are potentially dangerous because of their growth in a cramped space and the compressive phenomena they can cause. Stereota...
Eligibility Criteria
Inclusion
- Vestibular schwannoma's Patients for whom an indication of gammaknife radiosurgery was determined in a dedicated multidisciplinary consultation meeting, having not received previous treatment for this schwannoma.
- Patient affiliated to Social Security
- No opposition to participation
Exclusion
- History of prior treatment for the presented vestibular schwannoma (surgery, fractional radiotherapy)
- History of otological or otoneurological pathology associated with schwannoma
- Patient with type 2 neurofibromatosis
- Patient under legal protection
- Pregnant or breastfeeding women
Key Trial Info
Start Date :
May 21 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2028
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04859335
Start Date
May 21 2021
End Date
December 1 2028
Last Update
August 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Toulouse
Toulouse, France